SAMAR NOVAK: Open Payments
NPI 1114558996 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 34 payments from 9 companies in 2025. Trend: 2023 $551 · 2024 $499 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $193 |
| Novartis Pharmaceuticals Corporation | 7 | $122 |
| W. L. Gore & Associates, Inc. | 1 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Amgen Inc. | 2 | $37 |
| CVRx, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $20 |
| Philips North America LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: VYNDAQEL, GORE CARDIOFORM Septal Occluder, ELIQUIS, LEQVIO, ENTRESTO, REPATHA, Barostim Neo System, Wegovy.
Industry payments across AR — which companies pay providers there.
